Tumor necrosis factor alpha pathways develops liver apoptosis in type 1 diabetes mellitus.
暂无分享,去创建一个
M. P. Ceballos | D. Francés | C. Carnovale | M. Carrillo | M. Galleano | M. T. Ronco | G. Pisani | P. Ingaramo | J. Monti | Paola I. Ingaramo
[1] Gong Yang,et al. The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer , 2011, Clinical Cancer Research.
[2] J. Sastre,et al. Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats. , 2010, Free Radical Biology & Medicine.
[3] J. P. Parody,et al. Hyperglycemia induces apoptosis in rat liver through the increase of hydroxyl radical: new insights into the insulin effect. , 2010, The Journal of endocrinology.
[4] K. Okoshi,et al. Influence of rutin treatment on biochemical alterations in experimental diabetes. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] J. Y. Kim,et al. A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: controlled by ATF3. , 2009, Cellular signalling.
[6] S. Cuzzocrea,et al. Effects of genetic and pharmacological inhibition of TNF-alpha in the regulation of inflammation in macrophages. , 2009, Pharmacological research.
[7] D. Mikhailidis,et al. Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes. , 2009, Journal of diabetes and its complications.
[8] A. F. Mendes,et al. Nitric oxide synthase isoforms and NF-kappaB activity in normal and osteoarthritic human chondrocytes: regulation by inducible nitric oxide. , 2008, Nitric oxide : biology and chemistry.
[9] E. Mazzon,et al. Infliximab and Etanercept Are Equally Effective in Reducing Enterocyte APOPTOSIS in Experimental Colitis , 2008, International journal of medical sciences.
[10] Y. Bi,et al. Effect of early insulin therapy on nuclear factor κB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats , 2008, Acta Diabetologica.
[11] C. J. Jong,et al. Proapoptotic and antiapoptotic effects of hyperglycemia: role of insulin signaling. , 2008, Canadian journal of physiology and pharmacology.
[12] K. Makrilakis,et al. Cytokine Secretion in Long-standing Diabetes Mellitus Type 1 and 2: Associations with Low-grade Systemic Inflammation , 2008, Journal of Clinical Immunology.
[13] M. Foss,et al. Impaired cytokine production by peripheral blood mononuclear cells in type 1 diabetic patients. , 2007, Diabetes & metabolism.
[14] Ariel D. Quiroga,et al. Vascular endothelial growth factor and nitric oxide in rat liver regeneration. , 2007, Life sciences.
[15] E. Block,et al. Nitric oxide upregulation of caspase-8 mRNA expression in lung endothelial cells: role of JAK2/STAT-1 signaling , 2007, Molecular and Cellular Biochemistry.
[16] S. Klassen,et al. Nitric oxide differentially regulates the gene expression of caspase genes but not some autophagic genes. , 2007, Nitric oxide : biology and chemistry.
[17] P. Dandona,et al. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. , 2007, The American journal of cardiology.
[18] Wentao Gao,et al. Bid-Independent Mitochondrial Activation in Tumor Necrosis Factor Alpha-Induced Apoptosis and Liver Injury , 2006, Molecular and Cellular Biology.
[19] A. Wullaert,et al. Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes. , 2006, Biochemical pharmacology.
[20] A. Jevnikar,et al. Nitric oxide induces apoptosis in renal tubular epithelial cells through activation of caspase-8. , 2006, American journal of physiology. Renal physiology.
[21] Wan-Wan Lin,et al. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. , 2006, Cellular signalling.
[22] K. Gumireddy,et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. , 2005, Diabetes.
[23] T. Ganesan,et al. Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Kunihiro Suzuki,et al. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. , 2005, Biochemical and biophysical research communications.
[25] R. Bartrons,et al. Assessment of a dual regulatory role for NO in liver regeneration after partial hepatectomy: protection against apoptosis and retardation of hepatocyte proliferation , 2005, The FASEB Journal.
[26] K. Wellen,et al. Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.
[27] J.-T. Cheng,et al. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats , 2005, Diabetologia.
[28] Z. Madar,et al. Inducible Nitric Oxide Synthase Activity and Expression in Liver and Hepatocytes of Diabetic Rats , 2005, Pharmacology.
[29] K. Warpeha,et al. High glucose decreases intracellular glutathione concentrations and upregulates inducible nitric oxide synthase gene expression in intestinal epithelial cells. , 2004, Journal of molecular endocrinology.
[30] Xiao-Ming Yin,et al. Dissection of the multiple mechanisms of TNF‐α‐induced apoptosis in liver injury , 2004 .
[31] C. Carnovale,et al. Role of nitric oxide increase on induced programmed cell death during early stages of rat liver regeneration. , 2004, Biochimica et biophysica acta.
[32] R. Einspanier,et al. Insulin attenuates the systemic inflammatory response in endotoxemic rats. , 2004, Endocrinology.
[33] Peng Huang,et al. Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-κB* , 2004, Journal of Biological Chemistry.
[34] F. Murad,et al. Novel effects of nitric oxide. , 2003, Annual review of pharmacology and toxicology.
[35] J. Jakus,et al. Increased nitric oxide levels as an early sign of premature aging in diabetes. , 2003, Free radical biology & medicine.
[36] Simon Watkins,et al. Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement. , 2003, Gastroenterology.
[37] J. Tschopp,et al. Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.
[38] N. A. Callejas,et al. Nitric Oxide in Liver Inflammation and Regeneration , 2002, Metabolic Brain Disease.
[39] R. Marfella,et al. Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.
[40] P. Kubes,et al. Inducible nitric oxide synthase (iNOS) in endotoxemia: chimeric mice reveal different cellular sources in various tissues , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] B. Thorens,et al. cFLIP protein prevents tumor necrosis factor-alpha-mediated induction of caspase-8-dependent apoptosis in insulin-secreting betaTc-Tet cells. , 2002, Diabetes.
[42] H. Ha,et al. High Glucose Increases Inducible NO Production in Cultured Rat Mesangial Cells , 2001, Nephron.
[43] D R Alessi,et al. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.
[44] A. Bast,et al. Transcription factor NF-κB as a potential biomarker for oxidative stress , 2001, British Journal of Nutrition.
[45] S. Saccani,et al. Two Waves of Nuclear Factor κb Recruitment to Target Promoters , 2001, The Journal of experimental medicine.
[46] D. K. Kuharsky,et al. Activation of Pro-death Bcl-2 Family Proteins and Mitochondria Apoptosis Pathway in Tumor Necrosis Factor-α-induced Liver Injury* , 2001, The Journal of Biological Chemistry.
[47] G. Tiegs,et al. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. , 2001, The Journal of clinical investigation.
[48] P. Rösen,et al. Influence of diabetes on cardiac nitric oxide synthase expression and activity. , 2000, Biochimica et biophysica acta.
[49] Ko Jp. Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. , 2000 .
[50] D. Atar,et al. Lack of nuclear apoptosis in cardiomyocytes and increased endothelin-1 levels in a rat heart model of myocardial stunning , 2000, Basic Research in Cardiology.
[51] G. Evan,et al. Caspase‐8 in Apoptosis: The Beginning of “The End”? , 2000, IUBMB life.
[52] C. Carnovale,et al. Nitric oxide release and enhancement of lipid peroxidation in regenerating rat liver. , 2000, Journal of hepatology.
[53] Xiao-Ming Yin. Bid, a critical mediator for apoptosis induced by the activation of Fas/TNF-R1 death receptors in hepatocytes , 2000, Journal of Molecular Medicine.
[54] B. Brüne,et al. Nitric oxide (NO): an effector of apoptosis , 1999, Cell Death and Differentiation.
[55] R. Muniyappa,et al. Interleukin-1beta-induced nitric oxide production in rat aortic endothelial cells: inhibition by estradiol in normal and high glucose cultures. , 1999, Life sciences.
[56] J. Frölich,et al. Nitric oxide and inflammatory joint diseases. , 1998, British journal of rheumatology.
[57] A. Vanin,et al. Complexes of Fe2+ with diethyldithiocarbamate or N-methyl-D-glucamine dithiocarbamate as traps of nitric oxide in animal tissues: comparative investigations. , 1997, Biochimica et biophysica acta.
[58] O. Traub,et al. Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications. , 1995, The Western journal of medicine.
[59] H. Hartung,et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[60] K. Decker,et al. Epr evidence of nitric oxide production by the regenerating rat liver. , 1994, Biochemical and biophysical research communications.
[61] G. Fantuzzi,et al. Differential regulation of cytokine production in lipopolysaccharide tolerance in mice , 1993, Infection and immunity.
[62] D. Servent,et al. Nitric oxide, a biological effector , 1991, European Biophysics Journal.
[63] M. M. Esteban,et al. Normalization of the altered liver function tests after islet transplantation in diabetic rats. , 1990, Diabete & metabolisme.
[64] C. Carnovale,et al. Bile flow decrease and altered bile composition in streptozotocin-treated rats. , 1986, Biochemical pharmacology.
[65] C. Carnovale,et al. Reversible impairment of hepatobiliary function induced by streptozotocin in the rat , 1984, Experientia.
[66] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[67] W. Thasler,et al. Insulin Decreases Inflammatory Signal Transcription Factor Expression in Primary Human Liver Cells after LPS Challenge , 2008, Molecular medicine.
[68] Y. Iwasaki,et al. High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. , 2007, Journal of diabetes and its complications.
[69] S. Harrison. Liver disease in patients with diabetes mellitus. , 2006, Journal of clinical gastroenterology.
[70] L. Ragolia,et al. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. , 2000, American journal of physiology. Cell physiology.
[71] M. Lutter,et al. Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.
[72] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .